Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 59 of the 60 references it cites were found in a registry or an index.

Adaptive design methods in clinical trials–a review

Open access
Chow, Shein-Chung, Chang, Mark · 2008 · Orphanet Journal of Rare Diseases

Abstract

In recent years, the use of adaptive design methods in clinical research and development based on accrued data has become very popular due to its flexibility and efficiency. Based on adaptations applied, adaptive designs can be classified into three categories: prospective, concurrent (ad hoc), and retrospective adaptive designs. An adaptive design allows modifications made to trial and/or statistical procedures of ongoing clinical trials. However, it is a concern that the actual patient population after the adaptations could deviate from the originally target patient population and consequently the overall type I error (to erroneously claim efficacy for an infective drug) rate may not be controlled. In addition, major adaptations of trial and/or statistical procedures of on-going trials may result in a totally different trial that is unable to address the scientific/medical questions the trial intends to answer. In this article, several commonly considered adaptive designs in clinical trials are reviewed. Impacts of ad hoc adaptations (protocol amendments), challenges in by design (prospective) adaptations, and obstacles of retrospective adaptations are described. Strategies for the use of adaptive design in clinical development of rare diseases are discussed. Some examples concerning the development of Velcade intended for multiple myeloma and non-Hodgkin's lymphoma are given. Practical issues that are commonly encountered when implementing adaptive design methods in clinical trials are also discussed.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/1750-1172-3-11

Cites

59 of 59 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Response-adaptive randomization.
Figure 1 Response-adaptive randomization.CC BY · PubMed Central
Figure 2 Sample size re-estimation.
Figure 2 Sample size re-estimation.CC BY · PubMed Central
Figure 3 Phase II/III seamless trial design.
Figure 3 Phase II/III seamless trial design.CC BY · PubMed Central
Figure 4 Non-Hodgkin's lymphoma trial.
Figure 4 Non-Hodgkin's lymphoma trial.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 60 references

Research works printed but not linked: 2

  1. Whitehead J: Bayesian decision procedures with application to dose-finding studies. International Journal of Pharmaceutical Medicine. 1997, 11: 201-208.
  2. Wang SJ: Regulatory experience of adaptive designs in well-controlled clinical trials. Presented at Adaptive Designs: Opportunities, Challenges and Scope in Drug Development, Washington, DC. 2006

Cited by

See all 482

Metadata

Authors
Chow, S.-C., & Chang, M.
Affiliations
  • Duke University (US)
  • Takeda Oncology (United States) (US)
Corresponding author
Chow, Shein-Chung
Venue
Orphanet Journal of Rare Diseases
Published
2008-05-02
Volume
3
Issue
1
Pages
11-11
ISSN
1750-1172 (ISSN-L)
OpenAlex
W2044439361
Cited by
482
References
60
Citations by year
2026: 20 · 2025: 21 · 2024: 25 · 2023: 26 · 2022: 27 · 2021: 27 · 2020: 38 · 2019: 25 · 2018: 26 · 2017: 35 · 2016: 30 · 2015: 34 · 2014: 32 · 2013: 36 · 2012: 36
FWCI
2.11
Type
journal article
Language
en
Open access
Licence
  • cc-by
  • creativecommons.org/licenses/by/2.0 (tdm)
Locations
  • Orphanet Journal of Rare Diseases (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • National University of Singapore (submittedVersion, cc-by)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
Funders
  • School of Medicine, Duke University
  • Takeda Oncology
Topics
  • Physical Sciences › Mathematics › Statistics and Probability › Statistical Methods in Clinical Trials
  • Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Pharmaceutical studies and practices
  • Physical Sciences › Mathematics › Statistics and Probability › Statistical Methods and Bayesian Inference
Keywords
adaptive trial design, protocol modification, type I error control, rare disease drug development, bortezomib, multiple myeloma, non-Hodgkin lymphoma
MeSH terms
Clinical Trials as Topic, Humans, Random Allocation, Research Design, Statistics as Topic, Clinical Trials, Phase II as Topic, Clinical Trials, Phase III as Topic, Rare Diseases

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Adaptive design methods in clinical trials–a review. https://app.cochat.ai/papers/10.1186/1750-1172-3-11
The paper
Chow, S.-C., & Chang, M. (2008). Adaptive design methods in clinical trials–a review. Orphanet Journal of Rare Diseases. https://doi.org/10.1186/1750-1172-3-11

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.